APOLLO HOSPITALS ENTERPRISE LTD.
NSE : APOLLOHOSPBSE : 508869ISIN
CODE : INE437A01024Industry : Hospital & Healthcare ServicesHouse
: Apollo Hospitals
BSE5936.65-321.9 (-5.14 % )
PREV CLOSE (Rs.) 6258.55
OPEN PRICE (Rs.) 6257.90
BID PRICE (QTY) 5932.55 (28 )
OFFER PRICE (QTY) 5937.45 (33 )
VOLUME 44625
TODAY'S LOW / HIGH (Rs.)
52 WK LOW / HIGH (Rs.)
NSE5962.70 -295.9 (-4.73 % )
PREV CLOSE(Rs.) 6258.60
OPEN PRICE (Rs.) 6200.00
BID PRICE (QTY) 5962.70 (7 )
OFFER PRICE (QTY) 5965.00 (16 )
VOLUME 2363445
TODAY'S LOW / HIGH(Rs.)
52 WK LOW / HIGH (Rs.)
Company News
| Date | Heading | Details |
|---|---|---|
| 02-Apr-2024 | Apollo Hospitals Enterprise informs about change in directorate | <div style="text-align: justify;">Apollo Hospitals Enterprise has informed that as per the terms of appointment, Vinayak Chatterjee {DIN: 00008933), completed his second term as an Independent Director of Apollo Hospitals Enterprise ('the Company') as of 31st March 2024 and consequently ceased to be an Independent Director and a Member of the Board of Directors of the Company effective from the closing hours of 31st March 2024. The Board of Directors of the Company placed on record its appreciation for the valuable contributions and guidance provided by Vinayak Chatterjee during his tenure. Further informed that even after the cessation of office of Vinayak Chatterjee as an Independent Director of the Company, the Company would continue to be in compliance with the requirements of Regulation 17(1) of the SEBI LODR.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div><div style="text-align: justify;"><br></div> |
| 28-Feb-2024 | Apollo Hospitals Enterprise informs about loss of share certificate | <p style="text-align: justify;">Apollo Hospitals Enterprise has informed that the Company has received intimation from shareholder on February 28, 2024 regarding loss of share certificate. In accordance with Regulation 39(3) of the Regulations., the details of the said share certificate are enclosed. </p><p style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</p> |
| 19-Jan-2024 | Apollo Hospitals Enterprise informs about loss of share certificate | <p style="text-align: justify;">Apollo Hospitals Enterprise has informed that the Company has received intimation from shareholder on January 19, 2024 regarding loss of share certificate. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificate are enclosed.</p><p style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</p><div style="text-align: justify;"><br></div> |
| 23-Dec-2023 | Apollo Hospitals Enterprise informs about closure of trading window | <div style="text-align: justify;">Apollo Hospitals Enterprise has informed that pursuant to the Provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, (as amended) and the Company's Code of Conduct for Prevention of Insider Trading, the trading window of the Company will remain closed (for the purpose of consideration of unaudited financial results for the quarter and nine months period ending on 31st December 2023 along with other matters for which trading window is required to be closed) from Monday, 1st January 2024 till 48 hours after the announcement/ declaration of the unaudited financial results.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div> |
| 21-Nov-2023 | Apollo Hospitals Enterprise informs about details of loss of certificate | <div style="text-align: justify;">Apollo Hospitals Enterprise has informed that the Company has received intimation from shareholder on November 21, 2023 regarding loss of share certificate. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificate are enclosed. </div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div> |
| 10-Nov-2023 | Apollo Hospitals Enterprise inches up on reporting 17% rise in Q2 consolidated net profit | <p style="text-align: justify;">Apollo Hospitals Enterprise is currently trading at Rs. 5315.45, up by 18.00 points or 0.34% from its previous closing of Rs. 5297.45 on the BSE.</p><p style="text-align: justify;">The scrip opened at Rs. 5333.95 and has touched a high and low of Rs. 5337.25 and Rs. 5270.55 respectively. So far 2096 shares were traded on the counter.</p><p style="text-align: justify;">The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 5362.00 on 28-Jul-2023 and a 52 week low of Rs. 4078.40 on 15-Feb-2023.</p><p style="text-align: justify;">Last one week high and low of the scrip stood at Rs. 5337.25 and Rs. 5088.30 respectively. The current market cap of the company is Rs. 76169.20 crore.</p><p style="text-align: justify;">The promoters holding in the company stood at 29.33%, while Institutions and Non-Institutions held 64.98% and 5.69% respectively.</p><p style="text-align: justify;">Apollo Hospitals Enterprise has reported 5.63% rise in its net profit at Rs 294.80 crore for the quarter ended September 30, 2023 as compared to Rs 279.10 crore for the same quarter in the previous year. Total income of the company increased by 9.82% at Rs 1931.10 crore for Q2FY24 as compared to Rs 1758.50 crore for the corresponding quarter previous year. </p><p style="text-align: justify;">On consolidated basis, the company has reported 16.92% rise in its net profit at Rs 248.80 crore for Q2FY24 as compared to Rs 212.80 crore for the same quarter in the previous year. Total income of the company increased by 13.93% at Rs 4869.10 crore for Q2FY24 as compared to Rs 4273.70 crore for the corresponding quarter previous year.</p><div style="text-align: justify;"><br></div> |
| 10-Nov-2023 | Garden Reach Shipbuilders, Bharti Airtel and Aster DM Healthcare to see some action today | <p style="text-align: justify;"><b>Garden Reach Shipbuilders & Engineers</b> has received the letter of intent (LoI) from National Centre for Polar and Ocean Research (NCPOR) for award of contract towards construction and delivery of Ocean Research Vessel. The total contract value shall be approximate of Rs 840 crore including taxes. </p><p style="text-align: justify;">Within 1 year of the launch of Airtel 5G Plus, <b>Bharti Airtel </b>has over 1.6 million unique 5G customers in West Bengal. Airtel 5G Plus service is available across all the districts in the state within just 12 months of the launch. Airtel's 5G service is now available across all districts and union territories in the country. Airtel has extensively rolled out its network making its services available across all districts in West Bengal.</p><p style="text-align: justify;"><b>Aster DM Healthcare</b>'s wholly owned step-down material subsidiary -- Aster DM Healthcare FZC has incorporated Aster Shared Services Centre (ASSCPL), a wholly owned subsidiary Company in India on November 08, 2023. The main object of ASSCPL is to provide software solutions for information technology, telecommunications, other technology driven segments, back-office support services/ outsourcing services for all functions including human resources, finance, billing, accounts payable, accounts receivable, information technology, payroll, procurement, revenue cycle management and such other ancillary services in India and abroad.</p><p style="text-align: justify;"><b>Mahindra EPC Irrigation</b> has been awarded three contracts worth approximate Rs 6 crore from Office of the Asst. Engineer, Water User Association for supply of pressurized Micro Irrigation Systems for 1225 Ha. The said orders are expected to be completed in 4 months. </p><p style="text-align: justify;"><b>Ashok Leyland </b>has reported 3- fold jump in its consolidated net profit at Rs 569.31 crore for Q2FY24 as compared to Rs 185.80 crore for the same quarter in the previous year. Total income of the company increased by 19.15% at Rs 11463.03 crore for Q2FY24 as compared to Rs 9620.28 crore for the corresponding quarter previous year. </p><p style="text-align: justify;"><b>Apollo Hospitals Enterprise</b> has reported results for second quarter ended September 30, 2023 (Q2FY24). The company has reported 5.63% rise in its net profit at Rs 294.80 crore for the quarter under review as compared to Rs 279.10 crore for the same quarter in the previous year. Total income of the company increased by 9.82% at Rs 1931.10 crore for Q2FY24 as compared to Rs 1758.50 crore for the corresponding quarter previous year. On consolidated basis, the company has reported 16.92% rise in its net profit at Rs 248.80 crore for Q2FY24 as compared to Rs 212.80 crore for the same quarter in the previous year. Total income of the company increased by 13.93% at Rs 4869.10 crore for Q2FY24 as compared to Rs 4273.70 crore for the corresponding quarter previous year.</p><p style="text-align: justify;">Moody's has upgraded <b>Tata Motors</b>' corporate family rating (CFR) from ‘B1' to ‘Ba3', reflecting continued improvement in the company's credit profile. The ratings agency also upgraded Jaguar Land Rover Automotive CFR to ‘Ba3' from ‘B1.</p> |
| 09-Nov-2023 | Apollo Hospitals Enterprise gets nod for expansion plan | <p style="text-align: justify;">Apollo Hospitals Enterprise's board has approved an expansion plan of the company involving a balance capital outlay of around Rs 3435 crore after reckoning for land/ asset acquisition costs already incurred.</p><p style="text-align: justify;">This expansion plan is in line with the plan to expand footprint in identified strategic locations to drive continued business growth and cater to the increasing demand for quality healthcare services across the country. The Board of Directors of the Company at its meeting held on November 9, 2023, inter alia, approved the same. </p><p style="text-align: justify;">Apollo Hospitals Enterprise owns and operates chain of multi-specialty hospitals. It offers the services in the area of cardiology, cardiothoracic, orthopedics and joint replacement, spine surgery, oncology, etc.</p><div style="text-align: justify;"><br></div> |
| 09-Nov-2023 | Apollo Hospitals Enterprise reports 17% rise in Q2 consolidated net profit | <p style="text-align: justify;">Apollo Hospitals Enterprise has reported results for second quarter ended September 30, 2023 (Q2FY24). </p><p style="text-align: justify;">The company has reported 5.63% rise in its net profit at Rs 294.80 crore for the quarter under review as compared to Rs 279.10 crore for the same quarter in the previous year. Total income of the company increased by 9.82% at Rs 1931.10 crore for Q2FY24 as compared to Rs 1758.50 crore for the corresponding quarter previous year. </p><p style="text-align: justify;">On consolidated basis, the company has reported 16.92% rise in its net profit at Rs 248.80 crore for Q2FY24 as compared to Rs 212.80 crore for the same quarter in the previous year. Total income of the company increased by 13.93% at Rs 4869.10 crore for Q2FY24 as compared to Rs 4273.70 crore for the corresponding quarter previous year.</p><div style="text-align: justify;"><br></div> |
| 28-Oct-2023 | Apollo Hospitals Enterprise informs about board meeting | <div style="text-align: justify;">Apollo Hospitals Enterprise has informed that the Board of Directors of the Company will be meeting on Thursday, November 9, 2023, to consider the approval of the unaudited financial results (Standalone and Consolidated) for the quarter and six months ended 3Qth September 2023 and other related matters.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div><div style="text-align: justify;"><br></div> |
